hypothyroidism require a lifetime of thyroid therapy, it is important to distinguish these from milder and transient disease or from dyshormonogenesis as early as possible. Thyroid scintigraphy is one of the most effective aids in the specific differential diagnosis of primary congenital hypothyroidism. We believe that scintigraphy and other tests aimed at clarifying the diagnosis should be performed in all infants with this condition before starting thyroid treatment. We report our experience in 46 infants with congenital hypothyroidism, 40 of which had thyroid scintigraphy.
Materials and methods
In the 6.6 years between September l, 1978 and March 31, 1985, 166,300 newborn infants born at hospitals of the Northern California Kaiser Permanente Medical Care Program were screened for congenital hypothyroidism. Fullterm infants with T4 levels more than two standard deviations (> 2 SD) below the mean on filter-paper bloodspot tests also had TSH tested from these spots. All premature infants (birth weight < 2,500 g) and all infants in intensive care nurseries received the TSH testing. Adding these groups to the low T4 group of full-term infants resulted in TSH testing for 7.3% of all newborns (12,060 infants). In infants with TSH greater than 25 μΐυ/ml, serum testing was repeated. Both T4 and TSH were assayed from the filter-paper bloodspots by double isotope radioimmunoassay using reagents supplied by Nichols Institute Reference Laboratories, Los Angeles, California; follow-up on presumptive positive tests for T4 and TSH used the same method in fresh serum specimens. Triiodothyronine (Ta) uptake was assayed by the talc method of LIN and Dos REMEDIOS [11] . Technetium-99m imaging (Tc-99m) was performed by administering 200 μ(ϋί as pertechnetate intravenously and imaging with a pinhole collimator in 20 minutes. Iodine-123 (1-123) imaging was done by administering 5 μΟί orally as sodium iodide and imaging with a pinhole collimator in 24 hours. Use of Tc-99m and 1-123 imaging in newborn infants, including techniques and absorbed radiation dose, have recently been described [7] . In the 46 infants with congenital hypothyroidism, the procedure changed as the importance of thyroid scintigraphy was realized. Early in the study, in the few scans performed, Tc-99m was used; most recently, we have preferred to use 1-123 in scintigraphy [7] .
Clinical and laboratory follow-up evaluation of all cases in our Northern California facilities was monitored through a regional center having a medical director (E. J. S.) and full-time nurse specialist (M. B.), allowing consistency of diagnosis and management and prompt communication with the patient's primary physician.
Johanson-Blizzard syndrome [8] with subsequent marked developmental delay and short stature in spite of adequate thyroid replacement. Six children of hyperthyroid mothers had received propylthiouracil during pregnancy. All these infants had low T4 values with slightly elevated TSH (between 25-80 μΐυ/ml), but in all instances repeat serum studies before age 14 days showed spontaneous return of T4 and TSH values to normal; none of these is included in our series of hypothyroid infants. During the first two years of the study before the value of scintigraphy was recognized, only two of the six cases had this test; 38 of the subsequent 40 cases had scintigraphy.
Results
Of the 166,300 infants screened for T 4 , 12,060 (7.3%) were tested for TSH. Presumptive positive tests (low T4, initial TSH more than 25 μΐυ/ml) were found in 280 (1 : 655), 46 (1 : 3615) of which were diagnosed as having primary congenital hypothyroidism by demonstrating persistently high TSH levels at repeat serum testing. Of these 46 patients, data for 40 who had thyroid scintigraphy performed are summarized in table I. Eighteen (45%) of the 40 infants had normal thyroid scintigrams, 15 (37%) showed absence of the thyroid gland, and seven (18%), ectopic or hypoplastic glands. Although the athyrotic infants had significantly lower mean T4 and higher mean TSH values than those with ectopic or normal-appearing thyroid glands (p < 0.05), there was a wide range within each of the three groups, so that no conclusion regarding classification could be drawn in an individual case. All infants had the diagnosis confirmed and scintigraphy performed before starting therapy at the mean age of 14 days. One infant had Down syndrome (T 4 2.1, TSH 143, no scintigram performed). Two patients were twins: twin A had a normal scintigram and relatively mild disease, in which the TSH level rose from 67 to 136 μΐυ/ml in three weeks; twin B had athyrosis at scintigraphy with a TSH level of 1,500 μΐυ/ml. One patient had dysmorphic features suggesting
Discussion
Thyroid scintigraphy is a valuable technique for elucidating the specific diagnosis in congenital primary hypothyroidism, and we believe this imaging process should be performed in every case before starting what might be a lifetime of thyroid therapy. As pointed out by HEYMAN, et al. [6] , thyroid uptake and scintigrams differentiate athyrotic and ectopic hypothyroidism from other causes of abnormal thyroid function in the newborn infant and we agree with these authors that 1-123 is superior to Tc-99m for study of the thyroid gland in neonates. Moreover, this test need not delay diagnosis and treatment; in our series of 40 cases, the mean infant age at scintigraphy was 12 days and therapy was begun by the mean age of 14 days, well below the age reported in published series from other programs [5, 9, 10, 12, 14] . The longer delay in performing scintigraphy in the series of HEYMAN, et al. [6] perhaps represents difficulty in coordinating the multistate New England Regional Hypothyroid Screening Program, from which the cases were drawn. This emphasizes the discrepancy between the diagnostic and follow-up aspects of a large screening program and is a point in favor of smaller programs in which early, accurate diagnosis and prompt treatment can be more easily coordinated [15] .
Eighteen of our 40 patients were found to have apparently normal thyroid glands at scintigraphy compared with six of the 16 cases of HEY-MAN, et al. [6] , By contrast, earlier international studies suggested that thyroid dysgenesis was the predominant factor in congenital hypothyroidism. The Second International Conference on Neonatal Thyroid Screening [4] reported that 90% of primary congenital hypothyroidism is caused by thyroid dysgenesis, about two thirds being thyroid ectopia and one third agenesis. Of the 48 infants having scintigraphy in the Toronto series of PRICE, et al. [14] , 30 were described as having dysgenesis (athyrotic, ectopic, or hypoplastic). There are several possible reasons why the recent studies in this country find an anatomically normal or goitrous gland in a much larger percentage of cases. First, the etiology and incidence of the condition may differ from country to country. Second, improved techniques for thyroid scintigraphy are likely to demonstrate thyroid tissue in the neonate in instances when less advanced methods show no gland. Thus, false results would favor agenesis, resulting in a misleadingly high estimate. The absence of goitrous glands in our series compared with others [6, 14] deserves mention. Standards for normal thyroid gland size in the newborn are lacking. In the presence of thyroid tissue in the normal location without a clinically enlarged thyroid gland, we have hesitated to diagnose goiter. Moreover, since our patients were treated at a significantly younger age than in the previous series mentioned [5, 6, 9, 10, 12, 14] , it is conceivable that if therapy were delayed, in some of our patients a goiter might have developed. Continued experience in more patients, using newer improved techniques for thyroid scintigraphy, should settle the question of relative incidence of normal and dysgenetic glands in congenital hypothyroidism. Recent studies have suggested that ultrasonography and serum thyroglobulin measurements may be helpful in classifying congenital hypothyroidism [2, 3, 13] . Serial measurements of T4, free T4, Ta, and TSH may also aid in diagnosing borderline cases. In the absence of thyroid enlargement, correlation of these laboratory parameters with thyroid scintigraphy can be expected. For example, a minimal rise in TSH in conjunction with consistently normal or only slightly low T4, Ts, free T4, and thyroglobulin on serial measurements tends to make suspect a scintigram reflecting athyrosis. These correlations are well illustrated in our cases involving twins; the twin with athyrosis on a scintigram had very high and rising TSH (1,500 μΐυ/ml) and very low, falling T4 (0.7 ng/ml), whereas the twin with a normal scintigram had much lower TSH (maximum, 143 μΐυ/ml) and higher T4 (11.3 ng/ml).
Thyroid scintigraphy findings have clinical application in the decision to start and continue thyroid therapy. In proven athyrotic patients, continual treatment is necessary throughout life; the same is true in most patients with ectopic glands. In patients with normal-appearing thyroid glands at scintigraphy, the decision to treat varies in each case. In infants who show minimal laboratory evidence of congenital hypothyroidism, serial testing of serum for T4 and TSH for a few weeks might eliminate the need for treatment by demonstrating transient hypothyroidism with laboratory values returning to normal. In the presence of a normal scintigram, even if treatment is elected, therapy might be discontinued at an early age and the patient retested. In this group also, dyshormonogenesis, with its genetic implications, may occur.
The diagnosis of congenital hypothyroidism should be confirmed by detailed repeat and specific testing including thyroid scintigraphy before therapy is begun; this is necessary to avoid unnecessary thyroid treatment. In a screening program using an empirically selected low T4 level as the criterion for TSH testing, it is tempting to begin treatment before the diagnosis of primary hypothyroidism is confirmed by further diagnostic procedures. Although most large thyroid screening programs, California's included, have centralized, standardized laboratories with excellent quality control for screening procedures, the follow-up diagnostic testing and subsequent clinical care are more diffuse and less well monitored. Ad-ministering thyroid hormone to normal infants in therapeutic amounts may not be entirely harmless. Excess amounts have untoward effects, including premature closure of cranial sutures, and the effect of unnecessary prolonged administration to infants and young children is not known. Moreover, as has been shown in a Swedish hypothyroid screening program [1] , parents experience significant emotional trauma in feeling that their child has a congenital disorder.
In summary, congenital hypothyroidism represents a broad spectrum of disease anatomically and functionally. Thyroid scintigraphy helps differentiate the various forms of congenital hypothyroidism and elucidate severity and prognosis of the disease. Current techniques using 1-123 allow rapid, accurate performance of thyroid scintigraphy in the neonate; total body radiation exposure is insignificant, being equivalent to that received in a single chest xray film. Helping diagnose mild and transient hypothyroidism may decrease unnecessary treatment. It is only through thorough diagnostic testing before therapy in the immediate neonatal period and continued long-term follow-up after treatment that congenital hypothyroidism can be properly managed. Programs for detecting congenital hypothyroidism should incorporate diagnostic and follow-up features that are as rigorous as those for the screening process itself in order to realize their full potential.
Summary
Current newborn screening programs in California and most of the U. S. depend for diagnosis of congenital primary hypothyroidism on demonstrating an elevated thyrotropin (TSH) level in infants with the lowest 5% to 10% of thyroxine (T4) levels by filter-paper bloodspot test. The diagnosis of primary congenital hypothyroidism based on low T4 with high TSH fails to distinguish between transient hypothyroidism, ectopic or hypoplastic thyroid, athyrosis, dyshormonogenesis, and transient hyperthyrotropinemia. We screened 166,300 newborn infants for primary congenital hypothyroidism for 6.5 years and confirmed the diagnosis in 46 cases; none of these patients had a goiter. Thyroid scintigraphy was performed in 40 with technetium-99m (Tc-99m) in the first eight cases tested and iodine-123 (1-123) in 29 of the last 32 cases. Fifteen infants were athyroid and seven had ectopic or hypoplastic glands; in 18 the thyroid gland appeared normal (present, normal location). Congenital hypothyroidism represents a spectrum of diseases from transient underactivity to complete absence of the thyroid gland. We recommend that, before starting treatment, a specific anatomic and functional diagnosis be confirmed by thyroid scintigraphy and other thyroid function tests. 
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